Overview

Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients Undergoing Myocardial Perfusion Imaging

Status:
Completed

Trial end date:
2011-09-01

Target enrollment:

Participant gender:

Summary

The routine administration of 75 mg of intravenous aminophylline following regadenoson (Lexiscan®), a commonly used medication for nuclear stress testing of the heart, can reduce the gastrointestinal (diarrhea and stomach upset) and other side effects related to regadenoson.

Phase:

Phase 4

Details

Lead Sponsor:

Rush University Medical Center

Treatments:

Aminophylline
Regadenoson